Hims Hers Stumbles Open as Regulatory Damage Hits Outlook
Hims & Hers Health fell after guiding Q1 2026 revenue below expectations, citing a $65 million headwind from regulato...
Using Options To Manage Sp 500 Risk Retirement
Using Options To Manage Sp 500 Risk Retirement covers how options can hedge downside and manage volatility, with practical, retirement-focused guidance.
27,633 articles
Block Says Will More Jobs Cut Spark Debate as AI Push Intensifies
Block reveals a plan to slash thousands of roles with AI tools, but critics warn the move may miss broader shifts in ...
Bitcoin Dumped When Global Liquidity Surged: Markets React
Bitcoin has fallen about 50% from its October peak as global liquidity rose. Some analysts say bitcoin dumped when gl...
Ambiq Micro Stock Popped: Why the Rally Surged Today
Ambiq Micro shares jumped as investors priced in stronger demand for ultra-low-power edge AI technology. This article...
What Target's Michael Fiddelke Means for Investors Now
Target unveiled a bold turnaround, but questions linger about what Target's Michael Fiddelke may be missing about eve...
Polymarket Taps Palantir AI to Police Betting Markets
Polymarket is adopting an AI-driven monitoring system from Palantir and TWG Global to police betting activity in real...
Does Apple Have Hands? An Investor’s Take on a New Hit
Can Apple land another market-moving hit? This analysis weighs the signals, metrics, and scenarios investors should w...
Kraft Heinz, McCormick, Hormel: Who’s the Best Buy?
Kraft Heinz trimmed guidance after a challenging quarter, McCormick posted steady growth with margin pressure, and Ho...
Cardano (ADA) Poised Rally Hinged on a Key Trigger
Cardano (ADA) is flashing bullish signs as the broader crypto market stabilizes, with a crucial resistance level in s...
NVIDIA Deepens Grip Cloud with AWS Chip Deal and Beyond
A major AWS chip deal cements NVIDIA's role in cloud AI, even as AWS pursues its own chip path. This helps scale AI w...
Tesla Rivian: Which Stock Will Outperform the Market in 2026
Tesla posts stronger margins amid a delivery dip, while Rivian turns profitable on software and a hopeful R2 ramp. An...
Phathom Pharma Upgraded by Barclays to Overweight $18 Target
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status